Learning Objectives: Discuss the role of neuroimaging in the evaluation of Alzheimer’s Disease. Describe visual rating scales useful for assessing brain structures/atrophy. Identify key brain regions commonly affected in Alzheimer’s Disease. Recognize MRI findings in atypical presentations of Alzheimer’s Disease. Review the role of FDG-PET in the diagnosis of Alzheimer’s Disease.
- Provider:Norton Healthcare
- Activity Link: https://cmetracker.net/NHCCME/Publisher?page=pubOpen#/EventID/137445/
- Start Date: 2024-06-20 05:00:00
- End Date: 2024-06-20 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest